From: The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese
HCV-1 | HCV-2 | ||||||||
---|---|---|---|---|---|---|---|---|---|
SNP ID | SVR (+) | SVR (−) | P | OR (95% CI) | SNP ID | SVR (+) | SVR (−) | P | OR (95% CI) |
N (%) | N (%) | N (%) | N (%) | ||||||
rs1059513 | rs1059513 | ||||||||
A allele | 294 (90.2) | 195 (95.6) | 0.42 (0.20, 0.91) | A allele | 333 (93.5) | 32 (94.1) | 0.90 (0.20, 4.01) | ||
G allele | 32 (9.8) | 9 (4.4) | 0.0235* | 1 | G allele | 23 (6.5) | 2 (5.9) | 0.8954 | 1 |
rs703817 a | rs703817 | ||||||||
A allele | 80 (24.5) | 63 (31.2) | 0.72 (0.49, 1.06) | A allele | 93 (26.1) | 5 (14.7) | 2.05 (0.77, 5.45) | ||
G allele | 246 (75.5) | 139 (68.8) | 0.0948 | 1 | G allele | 263 (73.9) | 29 (85.3) | 0.1425 | 1 |
rs324015 a | rs324015 | ||||||||
A allele | 145 (44.5) | 89 (44.1) | 1.02 (0.71, 1.45) | A allele | 172 (48.3) | 20 (58.8) | 0.65 (0.32, 1.34) | ||
G allele | 181 (55.5) | 113 (55.9) | 0.9249 | 1 | G allele | 184 (51.7) | 14 (41.2) | 0.2416 | 1 |
rs3024974 | rs3024974 b | ||||||||
C allele | 258 (79.1) | 161 (78.9) | 1.01 (0.66, 1.56) | C allele | 285 (80.5) | 27 (79.4) | 1.07 (0.45, 2.56) | ||
T allele | 68 (20.9) | 43 (21.1) | 0.9518 | 1 | T allele | 69 (19.5) | 7 (20.6) | 0.8777 | 1 |